Therapy News and Research

RSS

Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis

Belgian physicians report they have cured a young patient with extensively drug-resistant tuberculosis (XDR-TB) using a novel two-drug combination developed by researchers at Albert Einstein College of Medicine of Yeshiva University. The report, published in the Pediatric Infectious Disease Journal, marks the first known clinical use of this treatment for XDR-TB, the most deadly form of the disease.

11 May 2011

Second subject enrolled in human embryonic stem cell therapy trial for subacute thoracic spinal cord injury

Researchers at Northwestern Memorial Hospital, Northwestern University Feinberg School of Medicine and The Rehabilitation Institute of Chicago (RIC) recently enrolled their first subject in a national clinical research trial of a human embryonic stem cell-based therapy for participants with a subacute thoracic spinal cord injury.

11 May 2011

Scientists unravel how genetic defects can help predict risk of sudden cardiac death

Sudden cardiac death is always a shocking, tragic event, especially when it occurs at a young age. But, for the first time, scientists are unraveling how genetic defects can help predict the risk of dying suddenly in individuals with one of the leading causes of this unfortunate phenomenon.

11 May 2011

New Crohn’s disease therapy on its way

In a new study on a drug called Stelara (ustekinumab) it was seen that 40% patients with moderate to severe Crohn's disease responded. Stelara, which is already approved to treat psoriasis, is a human interleukin (IL)-12 and IL-23 antagonist marketed by Centocor Ortho Biotech Inc. The study findings were presented at Digestive Disease Week 2011.

11 May 2011

FDA clears Meridian's new C. difficile immunoassay

Meridian Bioscience, Inc., Cincinnati, Ohio today announced that it has received clearance from the U.S. Food and Drug Administration for a new Clostridium difficile immunoassay named Premier C. difficile GDH.

11 May 2011

Roper Industries signs definitive agreement to acquire Northern Digital

Roper Industries, Inc. today announced that it has signed a definitive agreement to acquire Northern Digital, Inc., a leading provider of 3-D measurement technology for medical applications. Northern Digital will become part of Roper's medical platform.

10 May 2011

Independent investigator begins pump trial of Biodel's two ultra-rapid human insulin formulations

Biodel Inc. announced today that an independent investigator initiated a pump trial of Biodel's two ultra-rapid-acting formulations of recombinant human insulin.

10 May 2011

New study finds nitric oxide gas appears to affect source of sickle cell pain crises

Nitric oxide gas appears to directly impact the source of the classic, disabling pain crises of sickle cell disease, Georgia Health Sciences University researchers report.

10 May 2011

Insight into sensory recovery after face transplantation

Recovery of sensation after facial transplantation is similar to, or even better than, that achieved by conventional surgery to repair nerve injuries, reports a study in the May issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons.

10 May 2011

Inspire reports net loss of $17.6 million for first quarter 2011

Inspire Pharmaceuticals, Inc. announced today financial results for the first quarter ended March 31, 2011, reporting a net loss of $17.6 million or per common share, as compared to a net loss of $14.8 million, or per common share, for the same period in 2010.

10 May 2011

IUPUI psychology professor to receive 2011 Young Scientist award for alcoholism research

Stephen L. Boehm II, Ph.D., associate professor of psychology in the School of Science at Indiana University-Purdue University Indianapolis, has been named the 2011 Young Scientist of the Year by the International Behavioural and Neural Genetics Society. The award will be presented May 13 at the society's annual meeting in Rome, Italy.

10 May 2011

Elekta to integrate cancer workflow and patient management tools into IBA's Proteus TK2 center

Elekta, a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders, will integrate cancer workflow and patient management tools into the Proteus TK2, a turnkey proton therapy center from Belgium-based Ion Beam Applications.

From Elekta 10 May 2011

UCH to hold groundbreaking ceremony for $400M expansion at Anschutz Medical Campus

The University of Colorado Hospital is holding a groundbreaking ceremony to celebrate the $400 million expansion on Tuesday, May 24, from 5 to 6:30 p.m. at the Anschutz Medical Campus.

10 May 2011

Mary Ann Liebert's peer-reviewed journal highlights latest developments in ocular gene therapy

Disorders of the eye are excellent targets for gene therapy because the ocular environment is readily accessible, relatively easy to monitor, and sequestered from the rest of the body.

10 May 2011

Psychological distress affects IVF outcomes

There is no doubt that undergoing infertility treatment is stressful, with high rates of anxiety and depression reported by many patients. Mind/body therapies designed to help women reduce stress earlier in the treatment process result in higher pregnancy rates, but little is known specifically about the impact of these therapies on women undergoing in vitro fertilization (IVF).

10 May 2011

Treatment with estrogen-lowering drugs shrinks tumors and reduces mastectomy rates in breast cancer patients

In the first large trial of its kind in the United States, researchers have shown that estrogen-lowering drugs can shrink tumors and reduce mastectomy rates for patients with stage 2 or 3 breast cancer.

10 May 2011

Aethlon seeks FDA meeting for re-initiation of Hemopurifier IDE study

Aethlon Medical, Inc. announces that it has submitted a request to the U.S. Food and Drug Administration for a face-to-face meeting to discuss re-initiation of an Investigational Device Exemption (IDE) study of the Aethlon Hemopurifier in the United States.

10 May 2011

Hitachi to provide Mayo Clinic with two sets of proton beam therapy systems

Hitachi, Ltd. today announced that it has entered into an agreement to provide Mayo Clinic with its proton beam therapy (PBT) system. This next-generation technology has spot scanning capability for treating certain forms of cancer. The agreement includes PBT system maintenance for both facilities for 10 years following completion of the systems' installation.

10 May 2011

EpiCept first quarter net loss decreases to $2.5 million

EpiCept Corporation today announced operating and financial results for the three months ended March 31, 2011, and provided an update with respect to the Company's key business initiatives.

10 May 2011

MHA's annual awards recognize outstanding health care leaders, innovative programs

Innovative programs and outstanding leaders in health care were honored Friday, May 6 at the Minnesota Hospital Association's 27th annual awards ceremony at the Metropolitan Ballroom in Minneapolis.

10 May 2011

Therapy News and Research

Novel two-drug combination cures young patient with extensively drug-resistant tuberculosis

Second subject enrolled in human embryonic stem cell therapy trial for subacute thoracic spinal cord injury

Scientists unravel how genetic defects can help predict risk of sudden cardiac death

New Crohn’s disease therapy on its way

FDA clears Meridian's new C. difficile immunoassay

Roper Industries signs definitive agreement to acquire Northern Digital

Independent investigator begins pump trial of Biodel's two ultra-rapid human insulin formulations

New study finds nitric oxide gas appears to affect source of sickle cell pain crises

Insight into sensory recovery after face transplantation

Inspire reports net loss of $17.6 million for first quarter 2011

IUPUI psychology professor to receive 2011 Young Scientist award for alcoholism research

Elekta to integrate cancer workflow and patient management tools into IBA's Proteus TK2 center

UCH to hold groundbreaking ceremony for $400M expansion at Anschutz Medical Campus

Mary Ann Liebert's peer-reviewed journal highlights latest developments in ocular gene therapy

Psychological distress affects IVF outcomes

Treatment with estrogen-lowering drugs shrinks tumors and reduces mastectomy rates in breast cancer patients

Aethlon seeks FDA meeting for re-initiation of Hemopurifier IDE study

Hitachi to provide Mayo Clinic with two sets of proton beam therapy systems

EpiCept first quarter net loss decreases to $2.5 million

MHA's annual awards recognize outstanding health care leaders, innovative programs

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News